BOD Australia Ltd - Swisse Wellness and Bod launch first hemp products into 2,000 Australian stores
BOD Australia Ltd (ASX:BDA)

Swisse Wellness and Bod launch first hemp products into 2,000 Australian stores

Published Mar 30, 2020

What happened?


What's happened?

Bod Australia Ltd (ASX: BDA, “Bod”) have announced that it has launched nine hemp-based products for the Australian market with supplements and skincare brand Swisse Wellness Pty Ltd (“Swisse”). Initially, the hemp-based products will be stocked in approximately 2,000 locations of leading retailers, including Chemist Warehouse, Coles, and Priceline Pharmacy.

What are the key highlights?

  1. This is the launch of the Swisse hemp range into Australia, following an exclusive global partnership with Bod secured in July 2019 with Swisse’s parent company, Health and Happiness Group Ltd - H&H Group (“H&H”) (HKSE: 1112).
  2. A Swisse branded sales and marketing campaign, along with in store promotions are supporting the launch to market.
  3. Bod and H&H will continue to collaborate on new hemp-based products and progress entry into international markets to greatly broaden the sales footprint.

CEO's summary

Jo Patterson CEO of BOD Australia Ltd has provided a statement.
Jo Patterson
Jo Patterson
CEO, BOD Australia Ltd

“Launching nine products with such a recognised and trusted brand in Swisse is game changing for Bod. We anticipate considerable consumer uptake once stock is available for purchase. We look forward to providing regular updates to shareholders as sales build.”

Download Announcement

View this announcement as well as our full profile on the company.

Comments

Share your thoughts about this announcement...

Similar articles
Bod continues to achieve strong revenue growth in FY2020
What's happened? Bod Australia Ltd (ASX: BDA, “Bod”) advises that it has achieved strong revenue growth in recent months...
3 years ago
Bod continues to achieve upward trajectory in medicinal cannabis prescriptions
What's happened? Bod Australia Ltd (ASX: BDA, “Bod”) has advised that it is continuing to experience significant uptake...
3 years ago
First medical cannabis prescriptions received from UK patients participating in Project Twenty21
What's happened? Bod Australia Ltd (ASX: BDA, “Bod”) has confirmed first prescriptions of the Company’s MediCabilis™ med...
3 years ago
Around the web
Why these ASX firms are shying away from the pot stock label – Part Two
Neurotech says due to often negative publicity around cannabis companies it tends not to promote it...
via stockhead.com.au
Clinical results for ancient therapy help ASX cannabis stocks weed out competition
Several ASX companies are undergoing rigorous clinical trials to gain regulatory approval for their...
via stockhead.com.au
Weed Week: Decriminalising cannabis could save Aussie tax payers billions every year
Penington Institute says pot-related law enforcement costs us $1.7 billion a year   Local cannabis...
via stockhead.com.au
Powered by  
  • Company
    BOD Australia Ltd
  • Website
  • Sector
    Distributors
  • Industry
    Distributors
  • Code
    ASX:BDA
  • Socials
View BOD Australia Ltd's Profile

How do I invest?

Considering investing in BOD Australia Ltd?
Here's how to get started.
Low Cost Brokerage ASX Cheapest ASX Trading Platform
  1. 1

    Create account

    Open an account with an online broker of your choice. If you do not have an existing broker, consider Mawson Graham's A$9.50 flat fee platform.

    Sign up now »
  2. 2

    Search for ASX:BDA

    On your online investment platform search for the stock ticker code ASX:BDA to bring up the company's shares.

  3. 3

    Buy shares

    Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.

Up